Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Phosphorylation of serine residue 89 of human adenovirus E1A proteins is responsible for their characteristic electrophoretic mobility shifts, and its mutation affects biological function.
Smith CL
,
Debouck C
,
Rosenberg M
,
Culp JS
.
???displayArticle.abstract???
The shift in mobility on sodium dodecyl sulfate-polyacrylamide gel electrophoresis that is characteristic of the adenovirus E1A proteins is the result of posttranslational modification. In the present study, we demonstrate that phosphorylation of bacterially produced E1A in higher cell extracts occurs on serine and is responsible for the mobility shift. E1A protein expressed in Saccharomyces cerevisiae also undergoes the mobility shift due to serine phosphorylation. Site-directed mutagenesis was used to identify the serine residue responsible for the mobility shift. Six serine residues were altered to glycine within E1A. Substitution at serine residue 89 was shown to selectively prevent the mobility shift of both the 289R and 243R E1A proteins. We conclude that phosphorylation at serine 89 is the specific modification responsible for the mobility shift of E1A. Moreover, we demonstrate that the Ser-89-to-Gly mutation has no effect on trans activation or complementation of an E1A-deficient adenovirus. In contrast, the mutant protein does significantly reduce both the repression and transformation efficiency of E1A. The five other Ser-to-Gly mutation were also examined for functional effects. None affected trans activation, whereas repression and transformation functions were affected. One mutant affected transformation without affecting repression, suggesting that these functions are to some degree also separable. The relevance of phosphorylation to structure and activity of E1A and other nuclear oncogene proteins is discussed.
Alitalo,
Identification of nuclear proteins encoded by viral and cellular myc oncogenes.
, Pubmed
Alitalo,
Identification of nuclear proteins encoded by viral and cellular myc oncogenes.
,
Pubmed
Barber,
Modification of fos proteins: phosphorylation of c-fos, but not v-fos, is stimulated by 12-tetradecanoyl-phorbol-13-acetate and serum.
1987,
Pubmed
Baumann,
DNA-binding properties of phosphorylated and dephosphorylated D2-T antigen, a simian-virus-40 T-antigen-related protein.
1985,
Pubmed
Berk,
Adenovirus promoters and E1A transactivation.
1986,
Pubmed
Bockus,
Phosphorylation of polyomavirus large T antigen: effects of viral mutations and cell growth state.
1987,
Pubmed
Borrelli,
Adenovirus-2 E1A products repress enhancer-induced stimulation of transcription.
,
Pubmed
Chlebowski,
Calorimetry of alkaline phosphatase. Stability of the monomer and effect of metal ion and phosphate binding on dimer stability.
1979,
Pubmed
Curran,
Viral and cellular fos proteins: a comparative analysis.
1984,
Pubmed
Ferguson,
Transfer of functional adenovirus E1A transcription activator proteins into mammalian cells by protoplast fusion.
1986,
Pubmed
Ferguson,
E1A 13S and 12S mRNA products made in Escherichia coli both function as nucleus-localized transcription activators but do not directly bind DNA.
1985,
Pubmed
Ferguson,
Adenovirus E1a gene product expressed at high levels in Escherichia coli is functional.
1984,
Pubmed
,
Xenbase
Ferguson,
Isolation and analysis of an Abelson murine leukemia virus-encoded tyrosine-specific kinase produced in Escherichia coli.
1985,
Pubmed
Franza,
In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenes.
1986,
Pubmed
Gorman,
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
1982,
Pubmed
Gorman,
The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection.
1982,
Pubmed
Gorman,
Regulation of the yeast metallothionein gene.
1986,
Pubmed
Grässer,
Removal of serine phosphates from simian virus 40 large T antigen increases its ability to stimulate DNA replication in vitro but has no effect on ATPase and DNA binding.
1987,
Pubmed
Hann,
Proteins encoded by v-myc and c-myc oncogenes: identification and localization in acute leukemia virus transformants and bursal lymphoma cell lines.
1983,
Pubmed
Harlow,
Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products.
1985,
Pubmed
Hassauer,
Mapping of phosphorylation sites in polyomavirus large T antigen.
1986,
Pubmed
Hen,
A mutated polyoma virus enhancer which is active in undifferentiated embryonal carcinoma cells is not repressed by adenovirus-2 E1A products.
,
Pubmed
Hunkapiller,
Isolation of microgram quantities of proteins from polyacrylamide gels for amino acid sequence analysis.
1983,
Pubmed
Jones,
An adenovirus type 5 early gene function regulates expression of other early viral genes.
1979,
Pubmed
Jones,
Regulation of adenovirus transcription by an E1a gene in microinjected Xenopus laevis oocytes.
1983,
Pubmed
,
Xenbase
Kalderon,
In vitro mutagenesis of a putative DNA binding domain of SV40 large-T.
1984,
Pubmed
Kimelman,
E1a regions of the human adenoviruses and of the highly oncogenic simian adenovirus 7 are closely related.
1985,
Pubmed
Krippl,
Functions of purified E1A protein microinjected into mammalian cells.
1984,
Pubmed
Krippl,
Adenovirus type 12 E1A protein expressed in Escherichia coli is functional upon transfer by microinjection or protoplast fusion into mammalian cells.
1986,
Pubmed
Kunkel,
Rapid and efficient site-specific mutagenesis without phenotypic selection.
1985,
Pubmed
Leff,
Individual products of the adenovirus 12S and 13S EIa mRNAs stimulate viral EIIa and EIII expression at the transcriptional level.
1984,
Pubmed
Lillie,
Functional domains of adenovirus type 5 E1a proteins.
1987,
Pubmed
Lillie,
An adenovirus E1a protein region required for transformation and transcriptional repression.
1986,
Pubmed
Lucher,
Phosphorylation in vitro of Escherichia coli-produced 235R and 266R tumor antigens encoded by human adenovirus type 12 early transformation region 1A.
1985,
Pubmed
MacConnell,
Expression of FBJ-MSV oncogene (fos) product in bacteria.
1983,
Pubmed
Matlashewski,
Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene.
1984,
Pubmed
Miyamoto,
Production of human c-myc protein in insect cells infected with a baculovirus expression vector.
1985,
Pubmed
Moran,
Lytic and transforming functions of individual products of the adenovirus E1A gene.
1986,
Pubmed
Moran,
Multiple functional domains in the adenovirus E1A gene.
1987,
Pubmed
Mott,
Maximizing gene expression from plasmid vectors containing the lambda PL promoter: strategies for overproducing transcription termination factor rho.
1985,
Pubmed
Nevins,
Mechanism of activation of early viral transcription by the adenovirus E1A gene product.
1981,
Pubmed
Ramsay,
Phosphorylation of specific sites in the gag-myc polyproteins encoded by MC29-type viruses correlates with their transforming ability.
1982,
Pubmed
Reddy,
The genome of simian virus 40.
1978,
Pubmed
Richter,
Heterogeneity of adenovirus type 5 E1A proteins: multiple serine phosphorylations induce slow-migrating electrophoretic variants but do not affect E1A-induced transcriptional activation or transformation.
1988,
Pubmed
Richter,
A first exon-encoded domain of E1A sufficient for posttranslational modification, nuclear-localization, and induction of adenovirus E3 promoter expression in Xenopus oocytes.
1985,
Pubmed
,
Xenbase
Rowe,
Characterization of human adenovirus type 5 early region 1A polypeptides using antitumor sera and an antiserum specific for the carboxy terminus.
1983,
Pubmed
Ruley,
Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture.
,
Pubmed
Samad,
Mapping of phosphomonoester and apparent phosphodiester bonds of the oncogene product p53 from simian virus 40-transformed 3T3 cells.
1986,
Pubmed
Sanger,
DNA sequencing with chain-terminating inhibitors.
1977,
Pubmed
Scheidtmann,
Phosphorylation of simian virus 40 large T antigen: cytoplasmic and nuclear phophorylation sites differ in their metabolic stability.
1986,
Pubmed
Schneider,
Mutational analysis of the adenovirus E1a gene: the role of transcriptional regulation in transformation.
1987,
Pubmed
Seif,
The genome of human papovavirus BKV.
1979,
Pubmed
Simmons,
Phosphorylation downregulates the DNA-binding activity of simian virus 40 T antigen.
1986,
Pubmed
Spangler,
Activation of adenovirus promoters by the adenovirus E1A protein in cell-free extracts.
1987,
Pubmed
Tremblay,
Identification of the phosphorylation sites in early region 1A proteins of adenovirus type 5 by amino acid sequencing of peptide fragments.
1988,
Pubmed
Tsukamoto,
Genetic mapping of a major site of phosphorylation in adenovirus type 2 E1A proteins.
1986,
Pubmed
Van Beveren,
Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini.
1983,
Pubmed
van Ormondt,
Comparison of nucleotide sequences of the early E1a regions for subgroups A, B and C of human adenoviruses.
1980,
Pubmed
Van Roy,
Phosphorylation patterns of tumour antigens in cells lytically infected or transformed by simian virus 40.
1981,
Pubmed
Velcich,
Adenovirus E1a ras cooperation activity is separate from its positive and negative transcription regulatory functions.
1988,
Pubmed
Velcich,
Adenovirus E1a proteins repress transcription from the SV40 early promoter.
1985,
Pubmed
Watt,
Expression and characterization of the human c-myc DNA-binding protein.
1985,
Pubmed
Weinberg,
The action of oncogenes in the cytoplasm and nucleus.
1985,
Pubmed
Whyte,
Two regions of the adenovirus early region 1A proteins are required for transformation.
1988,
Pubmed
Wigler,
DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.
1979,
Pubmed
Yee,
Identification of human adenovirus early region 1 products by using antisera against synthetic peptides corresponding to the predicted carboxy termini.
1983,
Pubmed
Yee,
Analysis of multiple forms of human adenovirus type 5 E1A polypeptides using an anti-peptide antiserum specific for the amino terminus.
1985,
Pubmed
Zerler,
Different functional domains of the adenovirus E1A gene are involved in regulation of host cell cycle products.
1987,
Pubmed
